10q10k10q10k.net

vs

Side-by-side financial comparison of Ametek (AME) and Emerson Electric (EMR), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $2.0B, roughly 2.2× Ametek). Ametek runs the higher net margin — 19.9% vs 13.9%, a 6.0% gap on every dollar of revenue. On growth, Ametek posted the faster year-over-year revenue change (13.4% vs 4.1%). Emerson Electric produced more free cash flow last quarter ($602.0M vs $527.3M).

AMETEK, Inc. is an American multinational conglomerate and global designer and manufacturer of electronic instruments and electromechanical devices with headquarters in the United States and over 150 sites worldwide.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

AME vs EMR — Head-to-Head

Bigger by revenue
EMR
EMR
2.2× larger
EMR
$4.3B
$2.0B
AME
Growing faster (revenue YoY)
AME
AME
+9.3% gap
AME
13.4%
4.1%
EMR
Higher net margin
AME
AME
6.0% more per $
AME
19.9%
13.9%
EMR
More free cash flow
EMR
EMR
$74.7M more FCF
EMR
$602.0M
$527.3M
AME

Income Statement — Q4 2025 vs Q1 2026

Metric
AME
AME
EMR
EMR
Revenue
$2.0B
$4.3B
Net Profit
$398.6M
$605.0M
Gross Margin
36.0%
53.2%
Operating Margin
25.3%
Net Margin
19.9%
13.9%
Revenue YoY
13.4%
4.1%
Net Profit YoY
2.9%
3.4%
EPS (diluted)
$1.73
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align — see 8-quarter trend below.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.

Revenue
AME
AME
EMR
EMR
Q4 25
$2.0B
$4.3B
Q3 25
$1.9B
Q2 25
$1.8B
Q1 25
$1.7B
Q4 24
$1.8B
Q3 24
$1.7B
Q2 24
$1.7B
Q1 24
$1.7B
Net Profit
AME
AME
EMR
EMR
Q4 25
$398.6M
$605.0M
Q3 25
$371.4M
Q2 25
$358.4M
Q1 25
$351.8M
Q4 24
$387.3M
Q3 24
$340.2M
Q2 24
$337.7M
Q1 24
$310.9M
Gross Margin
AME
AME
EMR
EMR
Q4 25
36.0%
53.2%
Q3 25
36.3%
Q2 25
35.8%
Q1 25
36.1%
Q4 24
36.6%
Q3 24
36.0%
Q2 24
36.0%
Q1 24
34.1%
Operating Margin
AME
AME
EMR
EMR
Q4 25
25.3%
Q3 25
25.8%
Q2 25
26.0%
Q1 25
26.3%
Q4 24
26.6%
Q3 24
26.1%
Q2 24
25.8%
Q1 24
24.0%
Net Margin
AME
AME
EMR
EMR
Q4 25
19.9%
13.9%
Q3 25
19.6%
Q2 25
20.2%
Q1 25
20.3%
Q4 24
22.0%
Q3 24
19.9%
Q2 24
19.5%
Q1 24
17.9%
EPS (diluted)
AME
AME
EMR
EMR
Q4 25
$1.73
$1.07
Q3 25
$1.60
Q2 25
$1.55
Q1 25
$1.52
Q4 24
$1.67
Q3 24
$1.47
Q2 24
$1.45
Q1 24
$1.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest filing — the kind of financial-strength check premium terminals charge for.

Metric
AME
AME
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$458.0M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$10.6B
$20.3B
Total Assets
$16.1B
$41.9B
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.

Cash + ST Investments
AME
AME
EMR
EMR
Q4 25
$458.0M
Q3 25
$439.2M
Q2 25
$619.7M
Q1 25
$399.0M
Q4 24
$374.0M
Q3 24
$396.3M
Q2 24
$396.6M
Q1 24
$373.8M
Total Debt
AME
AME
EMR
EMR
Q4 25
$2.3B
Q3 25
Q2 25
Q1 25
Q4 24
$2.1B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AME
AME
EMR
EMR
Q4 25
$10.6B
$20.3B
Q3 25
$10.5B
Q2 25
$10.4B
Q1 25
$10.0B
Q4 24
$9.7B
Q3 24
$9.6B
Q2 24
$9.3B
Q1 24
$9.0B
Total Assets
AME
AME
EMR
EMR
Q4 25
$16.1B
$41.9B
Q3 25
$16.2B
Q2 25
$15.3B
Q1 25
$14.9B
Q4 24
$14.6B
Q3 24
$14.8B
Q2 24
$14.8B
Q1 24
$14.9B
Debt / Equity
AME
AME
EMR
EMR
Q4 25
0.21×
Q3 25
Q2 25
Q1 25
Q4 24
0.22×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Net income can be massaged; cash flow is harder to fake.

Metric
AME
AME
EMR
EMR
Operating Cash FlowLast quarter
$584.3M
$699.0M
Free Cash FlowOCF − Capex
$527.3M
$602.0M
FCF MarginFCF / Revenue
26.4%
13.9%
Capex IntensityCapex / Revenue; lower = less reinvestment burden
2.9%
2.2%
Cash ConversionOCF / Net Profit; >1× = earnings back up with cash
1.47×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$1.7B

8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.

Operating Cash Flow
AME
AME
EMR
EMR
Q4 25
$584.3M
$699.0M
Q3 25
$440.9M
Q2 25
$359.1M
Q1 25
$417.5M
Q4 24
$550.0M
Q3 24
$487.2M
Q2 24
$381.4M
Q1 24
$410.2M
Free Cash Flow
AME
AME
EMR
EMR
Q4 25
$527.3M
$602.0M
Q3 25
$420.0M
Q2 25
$329.8M
Q1 25
$394.5M
Q4 24
$498.3M
Q3 24
$460.9M
Q2 24
$360.0M
Q1 24
$382.6M
FCF Margin
AME
AME
EMR
EMR
Q4 25
26.4%
13.9%
Q3 25
22.2%
Q2 25
18.5%
Q1 25
22.8%
Q4 24
28.3%
Q3 24
27.0%
Q2 24
20.8%
Q1 24
22.0%
Capex Intensity
AME
AME
EMR
EMR
Q4 25
2.9%
2.2%
Q3 25
1.1%
Q2 25
1.6%
Q1 25
1.3%
Q4 24
2.9%
Q3 24
1.5%
Q2 24
1.2%
Q1 24
1.6%
Cash Conversion
AME
AME
EMR
EMR
Q4 25
1.47×
1.16×
Q3 25
1.19×
Q2 25
1.00×
Q1 25
1.19×
Q4 24
1.42×
Q3 24
1.43×
Q2 24
1.13×
Q1 24
1.32×

Financial Flow Comparison

Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.

Revenue Breakdown by Segment

AME
AME

Transferred At Point In Time$1.1B54%
Electronic Instruments Group$620.1M31%
Transferred Over Time$294.6M15%

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons